Chemo-flexibility in the era of immunotherapy: How can ICI-chemotherapy combinations be optimized in non-Oncogene- driven NSCLC?

Regeneron

Wednesday, 19.11.2025, 10:10 - 10:30, Dehli

Small Cell Lung Cancer: How treatment paradigm is evolving? A Patient Case- based Discussion

PharmaMar

Wednesday, 19.11.2025, 12:10 - 12:30, Lima

Multiple Myeloma: CD38-mAb based therapies in Ti NDMM

Sanofi

Wednesday, 19.11.2025, 13:10 - 13:30, Lima

Navigating CAR-T in the real world: how to select, sequence and manage CAR-T cell therapy in MM

Johnson & Johnson

Wednesday, 19.11.2025, 15:20 - 15:40, Kairo 1-2

How I treat relapsing endometrial and ovarian cancer: Effective treatment management of HER2+ patients

Daiichi Sankyo & AstraZeneca

Thursday, 20.11.2025, 10:10 - 10:30, Boston 1-2

Focus on IDHm Hematological Malignancies

Servier

Thursday, 20.11.2025, 15:20 - 15:40, Darwin